Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pathomics Oy
OY
Active
Y-tunnus 1848629-9
Liljasaarentie 6b, 00340
Helsinki
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2003 · 22 years old
2 employees
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Pathomics Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
84
73
—
54
41
Staff expenses
−1
−0
—
−0
−0
EBITDA
45
39
—
22
−1
Depreciation & amort.
—
—
—
−0
−0
EBIT
45
39
10
22
−1
Net financials
−2
−3
—
−8
−8
Profit before tax
43
37
—
14
−9
Tax
6
8
1
3
−0
Net profit
37
29
4
11
−9
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
795
778
1 199
46
22
Equity
596
615
1 587
626
611
Long-term debt
120
—
165
199
184
Short-term debt
79
168
8
16
70
Total debt
199
168
173
215
254
Financial ratios
5-year trend
EBITDA margin
-2.1%
This company
15.8%
Market median
-113% vs market
2021
2025
Equity ratio
2797.0%
This company
38.2%
Market median
+7222% vs market
2021
2025
Return on equity
-1.4%
This company
18.4%
Market median
-108% vs market
2021
2025
Net profit margin
-21.0%
This company
8.1%
Market median
-359% vs market
2021
2025
Asset turnover
1.87×
This company
1.12×
Market median
+67% vs market
2021
2025
Debt / equity
-0.96×
This company
0.62×
Market median
+255% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Pathomics Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network